How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab

Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.

Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.

pharma
Serum Survey Reveals Protein Patterns of Ill Health
Serum Survey Reveals Protein Patterns of Ill Health
Ruth Williams | Aug 2, 2018
Analyses of blood from thousands of people show distinct protein profiles are linked to complex diseases of aging.
FDA Approves First Marijuana-Derived Drug
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
CRISPR Patent Dispute Heard in Federal Court
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
NIH Won’t Use Industry Money for Opioid Research Initiative
NIH Won’t Use Industry Money for Opioid Research Initiative
Shawna Williams | Apr 19, 2018
The announcement comes after an agency working group recommends against an industry partnership on ethical grounds.
Infographic: Cancer Drug Pairings
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.
Pfizer to Halt Alzheimer’s and Parkinson’s Drug Research
Pfizer to Halt Alzheimer’s and Parkinson’s Drug Research
Jim Daley | Jan 7, 2018
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.
Dengue Vaccine Program Halted Over Safety Issues
Dengue Vaccine Program Halted Over Safety Issues
Shawna Williams | Dec 5, 2017
The drug may worsen future infections for people who haven't already been exposed to the virus.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Study: Hidden Conflicts of Interest Permeate Medicine
Study: Hidden Conflicts of Interest Permeate Medicine
Diana Kwon | Jan 19, 2017
Three investigations reveal the influence of industry money in patient advocacy groups, treatment guidelines, and Twitter feeds.